再生医療市場 - 2031 年の成長予測、統計、事実

  • Report Code : TIPHE100001194
  • Category : Life Sciences
  • No. of Pages : 201
Buy Now

再生医療市場は 2021 年に 117 億 7,000 万米ドルと評価され、米国に到達すると予測されています2031年までに374億8000万ドル。 2022 年から 2031 年にかけて 17.9% の CAGR で成長すると予想されています。

再生医療は、人間の細胞、組織、臓器を交換/再生して正常な機能を回復する方法を開発する革新的な医学分野です。身体自身の修復機構を刺激することで組織や器官を治癒します。再生医療により、科学者は研究室で組織や臓器を増殖させ、自然治癒できない場合にそれらを体内に安全に移植することができます。

遺伝子治療、幹細胞治療、組織工学の採用の増加。細胞治療および遺伝子治療の承認数が増加。再生医療分野における技術の進歩は、市場の成長を促進する重要な要因です。しかし、これらの治療法の高コストが市場の拡大を妨げています。

再生医療市場は、タイプに基づいて分析されます。アプリケーションと地理。このレポートは、市場動向、技術進歩、市場力学などのさまざまなパラメーターに重点を置き、再生医療市場に関する洞察と詳細な分析を提供するとともに、主要な市場プレーヤーの競争状況分析も提供します。

戦略的洞察

再生医療市場の収益性の高い地域

Regenerative Medicine Market

< h3>マーケット インサイト

細胞および遺伝子治療の承認数の増加が再生医療市場の成長を促進

細胞治療および遺伝子治療の数の増加が市場の成長を促進すると考えられます。たとえば、2022 年 5 月に米国食品医薬品局 (FDA) は、再発または難治性 (r/r) 濾胞性リンパ腫 (FL) の成人患者に対するノバルティス キムリア CAR-T 細胞療法を承認しました。キムリアは、ノバルティスとペンシルベニア大学ペレルマン医学部が共同開発した、最初に承認されたCAR-T細胞療法です。 2022 年 2 月、Janssen Biotech, Inc は、再発性または難治性の多発性骨髄腫の成人を治療するための CARVYKTI (ciltacabtagene autoleucel; cilta-cel) について米国 FDA の承認を取得しました。

  • 2022 年 8 月、Bluebird Bio, Inc. は、初の細胞ベースの遺伝子治療は、定期的に赤血球輸血を必要とするベータサラセミアを患う成人および小児患者を治療します。
  • 2021 年 3 月、米国 FDA は Celgene を承認しました。 Corporation の Abecma (idecabtagene vicleucel) は、治療に反応しなかった成人患者や、さまざまな種類の治療を受けても病気が再発した多発性骨髄腫の成人患者を治療する細胞ベースの遺伝子治療です。
< h3>タイプベースの洞察

再生医療市場は、種類に基づいて、細胞ベースの免疫療法および細胞療法製品、組織工学製品、および遺伝子治療製品に分類されます。細胞ベースの免疫療法および細胞療法製品セグメントは、2021 年に最大の市場シェアを保持し、2021 年に最高の CAGR を記録すると予想されています。予測期間。

種類別再生医療市場 – 2021 & 2031

 

Regenerative Medicine Market

アプリケーションベースの分析情報

アプリケーションに基づいて、再生医療市場は筋骨格系疾患、創傷治療、腫瘍学、眼科疾患、糖尿病に分類されます。2021 年には腫瘍学分野が最大の市場シェアを占め、最高の市場を記録すると推測されています2022 ~ 2031 年の CAGR。

新型コロナウイルス感染症(COVID-19)のパンデミックは、新型コロナウイルス感染症患者に対する新しい治療法開発の緊急性により、市場関係者に成長の機会をもたらしました。細胞および遺伝子治療の研究業界では、いくつかの研究プロジェクトが開始されました。たとえば、 2021 年 11 月、Longeveron Inc. は、新型コロナウイルス感染症による軽度から重度の急性呼吸窮迫症候群 (ARDS) に苦しむ成人を対象に、Longeveron 間葉系幹細胞 (LMSC) の安全性をテストする第 1 相試験を開始しました。< /p>

2022 年、北米が再生医療市場で最大のシェアを占めました。市場の成長は、再生医療分野での研究開発活動の高まりによるものです。アジア太平洋地域が最も早く記録されると予想されています予測期間中のCAGR.中国、日本、インドがこの地域の再生医療市場に大きく貢献している.幹細胞研究の増加、細胞および遺伝子研究に対する政府支援の増加、バイオテクノロジーインフラの改善が再生医療市場を牽引する要因となっているAPAC における市場の成長。

再生医療市場は地理的に、北米(米国、カナダ、メキシコ)、欧州(英国、ドイツ、フランス、イタリア、スペイン、その他の欧州)に分類されます。アジア太平洋 (中国、日本、インド、韓国、オーストラリア、その他のアジア太平洋地域)、中東およびアフリカ (UAE、サウジアラビア、アフリカ、およびその他の中東およびアフリカ)、および南および中米 (ブラジル、アルゼンチン、およびその他の南米および中米)。

会社概要

  • インテグラ ライフサイエンス
  • Gilead Sciences, Inc.
  • ノバルティス AG 
  • ベリセル株式会社
  • Wright Medical Group NV
  • MiMedx グループ
  • Osiris Therapeutics, Inc.
  • ストライカー コーポレーション
  • Spark Therapeutics, Inc.
  • メドトロニック plc
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the expected CAGR of the Regenerative Medicine Market?

The Regenerative Medicine Market is expected to register a CAGR of 15.4% from 2023-2031.

What are the driving factors impacting the Regenerative Medicine Market?

The major factors impacting the Regenerative Medicine Market are: Growing Focus on Stem Cell Research, Rising Prevalence of Chronic Diseases, and Advancements in Gene Therapy

What are the future trends in the Regenerative Medicine Market?

Key future trends in this market are - Increase in stem cell research, Adoption of 3D bioprinting, Advances in tissue engineering

Which are the key players in the Regenerative Medicine Market?

Key companies in this market are: Integra LifeSciences Corporation, Gilead Sciences, Novartis, Vericel Corporation, Wright Medical MiMedx, Osiris Therapeutics, Stryker Corporation, Spark Therapeutics

What are the deliverable formats of Regenerative Medicine Market report?

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

What are the options available for the customization of this report?

Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

1. Integra LifeSciences Corporation
2. Gilead Sciences
3. Novartis
4. Vericel Corporation
5. Wright Medical
6. MiMedx
7. Osiris Therapeutics
8. Stryker Corporation
9. Spark Therapeutics
10. Medtronic
11. 3M
12. Allergan Plc
13. Aspect Biosystems
14. Bluebird Bio
15. Amgen, Inc.
16. Smith and Nephew Plc
17. Corestem, Inc.
18. Organogenesis
19. Kite Pharma
20. Spark Therapeutics


Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.